Why the study?
What are the long-term clinical outcomes of patients with native valve infective endocarditis?
What are the long-term clinical outcomes of patients with native valve infective endocarditis?
Native valve infective endocarditis carries significant long-term morbidity and mortality, with high rates of death and eventual need for valve replacement.
Answers are grounded in this paper and cite their sources.
High long-term mortality and valve replacement rates in native valve IE underscore poor prognosis; extends observational data but leaves optimal strategies open.
Seventy-eight consecutive episodes of infective endocarditis on native valves have been prospectively treated and followed-up after discharge from 1975 to 1982 (mean follow-up period 31 months). Twenty one patients needed valvular replacement in the active phase of the disease. Overall mortality was 15 cases, 7 from the medical group and 8 from the surgical group. At last clinical control 21 from the 46 survivors of the medical group remained asymptomatic, 17 had needed valvular replacement, 5 had died 2 of congestive heart failure and 3 (addicts) were lost to follow-up. From the 13 survivors of the surgical group 8 remained asymptomatic with good prosthetic function, 4 had needed reoperation due to severe periprosthetic leak and 1 died suddenly during follow-up. Figures at the end of follow-up showed that 28% of the initial patients had died, 39% carried a valvular prosthesis and 28% remained asymptomatic. A retrospective analysis of factors predictive of poor prognosis has been carried out.
No takes yet. Share an insight, caveat, or question.
Tornos-Mas et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: